Uxin Q1 2025 Earnings Mixed Results Amid Challenging Market Conditions Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amid Quiet Trading Session SSYS Q1 2026 Earnings Narrower Loss Surprises Market Shares Rally NOK Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline PRA Group Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance